Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Zineh

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Clinical Pharmacology and Therapeutics|January 18, 2024
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic ProteinsYow-Ming C Wang, Ping Ji, Sudharshan Hariharan, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
The Future of Clinical Translational PharmacologyMatthew L Rizk, Anuradha Ramamoorthy, Stephani L Stancil, et al.
The AAPS Journal|February 29, 2020
Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and AutoinjectorsPing Hu, Jie Wang, Jeffery Florian, et al.
Pain Medicine (Malden, Mass.)|December 5, 2021
Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of AbuseSrikanth C Nallani, Wenjing Li, Silvia N Calderon, et al.
Clinical Pharmacology and Therapeutics|December 9, 2017
Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug AdministrationDionna J Green, Xiaomei I Liu, Tianyi Hua, et al.
Clinical Pharmacology and Therapeutics|May 21, 2020
Role of Guidance and Policy in Enhancing the Impact of Clinical Pharmacology in Drug Development, Regulation, and UseRajanikanth Madabushi, Elimika Pfuma Fletcher, Jeffry Florian, et al.
Journal of Clinical Pharmacology|April 9, 2014
Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizersRichard B Horenstein, Rajnikanth Madabushi, Issam Zineh, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 23, 2013
Continuing to strengthen FDA's science approach to emerging technologiesRachael Anatol, Steven Bauer, Suzanne Epstein, et al.
Pacing and Clinical Electrophysiology : PACE|June 23, 2007
The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patientsSamuel F Sears, Lauren D Vazquez Sowell, Emily A Kuhl, et al.
Eclinicalmedicine|September 29, 2021
Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidanceLiang Zhao, Zhichuan Li, Lanyan Fang, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|January 18, 2024
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic ProteinsYow-Ming C Wang, Ping Ji, Sudharshan Hariharan, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
The Future of Clinical Translational PharmacologyMatthew L Rizk, Anuradha Ramamoorthy, Stephani L Stancil, et al.
The AAPS Journal|February 29, 2020
Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and AutoinjectorsPing Hu, Jie Wang, Jeffery Florian, et al.
Pain Medicine (Malden, Mass.)|December 5, 2021
Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of AbuseSrikanth C Nallani, Wenjing Li, Silvia N Calderon, et al.
Clinical Pharmacology and Therapeutics|December 9, 2017
Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug AdministrationDionna J Green, Xiaomei I Liu, Tianyi Hua, et al.
Clinical Pharmacology and Therapeutics|May 21, 2020
Role of Guidance and Policy in Enhancing the Impact of Clinical Pharmacology in Drug Development, Regulation, and UseRajanikanth Madabushi, Elimika Pfuma Fletcher, Jeffry Florian, et al.
Journal of Clinical Pharmacology|April 9, 2014
Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizersRichard B Horenstein, Rajnikanth Madabushi, Issam Zineh, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 23, 2013
Continuing to strengthen FDA's science approach to emerging technologiesRachael Anatol, Steven Bauer, Suzanne Epstein, et al.
Pacing and Clinical Electrophysiology : PACE|June 23, 2007
The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patientsSamuel F Sears, Lauren D Vazquez Sowell, Emily A Kuhl, et al.
Eclinicalmedicine|September 29, 2021
Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidanceLiang Zhao, Zhichuan Li, Lanyan Fang, et al.
Pageof 13